Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Conditioning Regimens

Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors

Bone Marrow Transplantation volume 34, pages 305–307 (2004)Cite this article

Summary:

Allogeneic hematopoietic stem cell transplantation (SCT) from unaffected donors remains the only modality for the correction of hematological abnormalities in Fanconi anemia (FA) patients. We performed four HLA-matched related donor SCT using a novel irradiation and cyclophosphamide-free conditioning regimen. The protocol included fludarabine 150 mg/m2, busulfan 4 mg/kg, and antithymocyte globulin 90 mg/kg. Graft-versus-host disease (GVHD) prophylaxis was cyclosporin A, MTX, and daclizumab. The engraftment and occurrence of full stable donor hemopoiesis was rapid in all cases with minimal short-term toxic complications. There were no infections or febrile episodes during the inpatient phase. Three patients developed acute GVHD grade I–II involving gut and skin and one patient progressed to extensive chronic GVHD. The preparative conditioning regimen is safe and associated with low organ toxicity and effective immunosupression for the stable engraftment in FA patients undergoing SCT with matched related donors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Young N, Alter B (eds.). Clinical features of Fanconi's anemia. In: Aplastic Anemia, Acquired and Inherited. Saunders: Philadelphia, 1994; pp 275–309.

    Google Scholar 

  2. Sasaki M, Tonomura A . A high susceptibility of Fanconi's anaemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973; 33: 1829–1836.

    CAS  PubMed  Google Scholar 

  3. Gluckman E, Devergie A, Dutreix J . Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Brit J Haematol 1983; 54: 431–440.

    Article  CAS  Google Scholar 

  4. Gluckman E, Auerbach A, Horowitz M et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86: 2856–2862.

    CAS  PubMed  Google Scholar 

  5. Socie G, Devergie A, Girinski T et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patents transplanted from a sibling-donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249–255.

    Article  CAS  PubMed  Google Scholar 

  6. Kurre P, Pulspipher M, Woolfrey A et al. Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from HLA-matched unrelated donor. J Pediatr Hematol/Oncol 2003; 25: 581–583.

    Article  Google Scholar 

  7. de la Fuente J, Reiss S, McCloy M et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003; 32: 653–656.

    Article  CAS  PubMed  Google Scholar 

  8. Flowers M, Zanis J, Pasquini R et al. Marrow transplantation for Fanconi anemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol 1996; 92: 699–706.

    Article  CAS  PubMed  Google Scholar 

  9. Rossi G, Giorgiani G, Comoli P et al. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation. Bone Marrow Transplant 2003; 31: 437–440.

    Article  CAS  PubMed  Google Scholar 

  10. Kapelushnik J, Or R, Slavin S, Nagler A . A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 1997; 20: 1109–1110.

    Article  CAS  PubMed  Google Scholar 

  11. Aker M, Varadi G, Slavin S, Nagler A . Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anaemia. J Pediatr Hematol/Oncol 1999; 21: 237–239.

    Article  CAS  Google Scholar 

  12. Dufour C, Rondelly R, Locatelli F et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of Associazione Italiana di ematologia ed oncologia pediatrica (AIEOP)-Gruppo Italiano trapianto di midollo osseo (GITMO). Br J Haematol 2001; 112: 796–805.

    Article  CAS  PubMed  Google Scholar 

  13. Champlin R, Horowitz M, van Bekkum D et al. Graft failure following bone marrow transplantation for severe aplastic anaemia: risk factors and treatment results. Blood 1989; 73: 606–613.

    CAS  PubMed  Google Scholar 

  14. Guardiola P, Pasquini R, Dokai I et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422–429.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplantation Unit, Russian Institute for Pediatric Hematology, Russian Children's Hospital, Moscow, Russia

    A A Maschan, P E Trakhtman, D N Balashov, I P Shipicina, E V Skorobogatova, Y V Skvortsova, Z M Dyshlevaja, E V Samochatova & A G Rumiantsev

Authors
  1. A A Maschan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P E Trakhtman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D N Balashov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I P Shipicina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E V Skorobogatova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y V Skvortsova
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Z M Dyshlevaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E V Samochatova
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A G Rumiantsev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P E Trakhtman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maschan, A., Trakhtman, P., Balashov, D. et al. Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors. Bone Marrow Transplant 34, 305–307 (2004). https://doi.org/10.1038/sj.bmt.1704580

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704580

Keywords

This article is cited by

Search

Advanced search

Quick links